PLOD1 and polycystic ovary syndrome: RJ at the dose of 200 mg/kg for 4 weeks significantly improved reproductive hormone levels (T, E2, FSH, LH), estrus cycle regularity, ovarian oxidant-antioxidant status (MDA, TAC, GPx), and ovarian histology in a PCOS animal model.